Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perampanel effects on cortical inhibition in refractory epilepsy assessed by TMS
NL-OMON47007Active, not recruiting
- Sponsor
- SEIN
- Start
- Sep 2016
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of perampanel in epilepsy and Focal Onset Epilepsy, sponsored by SEIN. Primary endpoints: Change in long interval intracortical inhibition at 250 ms, Change in cortical excitability parameters and 1 more. Started Sep 2016; status: active, not recruiting.
02
Drugs
perampanel
03
Conditions
epilepsyFocal Onset Epilepsy
Beyond the preview
Go deeper on NL-OMON47007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47007.